Jump to navigation Jump to search
|Source||Humanized (from mouse)|
|Target||interleukin 6 receptor|
|Chemical and physical data|
|Molar mass||143416.47 g·mol−1|
- World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 114" (PDF). WHO Drug Information. 29 (4).
- Statement On A Nonproprietary Name Adopted By The USAN Council - Satralizumab, American Medical Association.
- "Chugai Presents Results from Phase III Study of Satralizumab in NMOSD at ECTRIMS 2018".
|This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.|